- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02349438
Assessment of Contact Lens Wettability Using Wavefront Aberrometry
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
This study will test the feasibility that differences in contact lens wettability can be measured with a wavefront sensor.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Queensland
-
Kelvin Grove, Queensland, Australia, 4059
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy males or females that are at least 18 to no more than 40 years of age.
- The subject must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must possess a wearable pair of spectacles with distance vision correction which provide satisfactory vision.
- The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of lens wear per week for a minimum of 1 month prior to the study) or has sufficient prior experience with soft contact lens wear (defined as a minimum of 30 days of lens wear during the last 5 years).
- The subject's vertexed best sphere distance refraction must be between -0.75 and -5.00 D in both eyes.
- Cylinder refraction less than or equal to -0.75 D in both eyes (any axis).
- The subject must have corrected visual acuity of 20/20 or better in each eye.
Exclusion Criteria:
- Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
- Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
- Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
- Any known hypersensitivity or allergic reaction to contact lens solutions or sodium fluorescein dye.
- Any previous ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.)
- Current wearers of rigid or hybrid contact lenses.
- Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by keratometry.
- Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
- History of binocular vision abnormality or strabismus.
- Employee of the investigational clinic (e.g. Investigator, Coordinator, Technician).
- Clinically significant (grade 3 or 4) corneal edema, pterygium, corneal vascularization, corneal staining, or any other abnormalities of the cornea or conjunctiva which may interfere with the study measurements.
- Strabismus, suppression or amblyopia.
- Any ocular infection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: senofilcon A
The lenses will be worn for 2 hours in both eyes, and not dispensed
|
A soft spherical contact lens
|
|
Active Comparator: lotrafilcon A
The lenses will be worn for 2 hours in both eyes, and not dispensed
|
A soft spherical contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking
Time Frame: 2 hours post insertion
|
Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking.
The average HO RMS was reported for each lens.
Lower values indicate better outcome.
|
2 hours post insertion
|
|
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink
Time Frame: 2 hours post insertion
|
Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking.
The average HO RMS was reported for each lens.
Lower values indicate better outcome.
|
2 hours post insertion
|
|
Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink
Time Frame: 2 hours post insertion
|
Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking.
The average HO RMS was reported for each lens.
Lower values indicate better outcome.
|
2 hours post insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
January 22, 2015
First Submitted That Met QC Criteria
January 27, 2015
First Posted (Estimate)
January 28, 2015
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
November 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- CR-5685
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Acuity
-
Mayo ClinicNot yet recruitingVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchQueensland University of TechnologyCompleted
-
Alcon ResearchCompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on lotrafilcon B
-
Indiana UniversityAlcon ResearchCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CIBA VISIONCompleted
-
Alcon ResearchCompleted